Key result
Cannabinoid-like plant compounds show potential therapeutic roles in cardiovascular disorders via endocannabinoid modulation.
Answers are grounded in this paper and cite their sources.
Nowadays cardiovascular diseases (CVDs) are the major causes for the reduction of the quality of life. The endocannabinoid system is an attractive therapeutic target for the treatment of cardiovascular disorders due to its involvement in vasomotor control, cardiac contractility, blood pressure and vascular inflammation. Alteration in cannabinoid signalling can be often related to cardiotoxicity, circulatory shock, hypertension, and atherosclerosis. Plants have been the major sources of medicines until modern eras in which researchers are experiencing a rediscovery of natural compounds as novel therapeutics. One of the most versatile plant is Cannabis sativa L., containing phytocannabinoids that may play a role in the treatment of CVDs. The aim of this review is to collect and investigate several less studied plants rich in cannabinoid-like active compounds able to interact with cannabinoid system; these plants may play a pivotal role in the treatment of disorders related to the cardiovascular system.
No takes yet. Share an insight, caveat, or question.
Dimmito et al. (2021) conducted a review in Cardiovascular diseases. Plant cannabinoids and cannabinoid-like active compounds was evaluated. Plants rich in cannabinoid-like active compounds interact with the endocannabinoid system and may play a therapeutic role in cardiovascular disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: